Wolverine Trading, LLC Abbott Laboratories Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.38 Million - $1.63 Million	13,800 Added 5.94%	246,300 $28.1 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $1.24 Million - $1.38 Million	12,300 Added 5.59%	232,500 $24.2 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $7.03 Million - $7.77 Million	-64,200 Reduced 22.57%	220,200 $25 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.28 Million - $4.02 Million	36,400 Added 14.68%	284,400 $31.3 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $496,756 - $596,024	5,200 Added 2.14%	248,000 $24 Million
Q2 2023 Aug 23, 2023	SELL	$100.78 - $112.29 $493,822 - $550,221	-4,900 Reduced 1.98%	242,800 $26.5 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $6.75 Million - $7.95 Million	-69,700 Reduced 21.96%	247,700 $24.5 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $3.25 Million - $3.81 Million	-34,200 Reduced 9.73%	317,400 $34.8 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $7.47 Million - $8.65 Million	77,200 Added 28.13%	351,600 $34.6 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $5.72 Million - $6.91 Million	-56,000 Reduced 16.95%	274,400 $29.9 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $37.7 Million - $45.9 Million	330,400 New	330,400 $39.8 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $30.3 Million - $37.1 Million	-262,400 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $30.6 Million - $33.9 Million	262,400 New	262,400 $31.3 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $12.8 Million - $15.1 Million	-120,900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $10.8 Million - $12.8 Million	-99,500 Reduced 45.15%	120,900 $14.5 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $1.74 Million - $1.9 Million	16,600 Added 8.15%	220,400 $23.9 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $1.59 Million - $1.94 Million	17,400 Added 9.33%	203,800 $21.4 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $1.75 Million - $2.23 Million	-22,800 Reduced 10.9%	186,400 $16.6 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $527,688 - $771,624	-8,400 Reduced 3.86%	209,200 $16.6 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $2.1 Million - $2.33 Million	-26,700 Reduced 10.93%	217,600 $18.9 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1.54 Million - $1.67 Million	-18,800 Reduced 7.15%	244,300 $20 Million
Q2 2019 Aug 20, 2019	SELL	$72.88 - $85.0 $1.36 Million - $1.58 Million	-18,600 Reduced 6.6%	263,100 $22.1 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $18.7 Million - $22.6 Million	281,700 New	281,700 $22.5 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $9.04 Million - $10.9 Million	-148,700 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $8.37 Million - $9.46 Million	148,700 New	148,700 $8.91 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $10.7 Million - $11.4 Million	-199,000 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $9.56 Million - $10.7 Million	199,000	199,000 $10.6 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.6 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.3 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.96 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.68 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.23 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account